Brainsway (BWAY) Chief Scientist discloses 1,079,305-share equity stake on Form 3

Rhea-AI Filing Summary

Brainsway Ltd. executive Dr. Yiftach Roth, the Chief Scientist, filed an initial statement of beneficial ownership showing he holds 1,079,305 Ordinary Shares. This figure includes shares held jointly with his spouse, additional individually held shares, and unvested restricted stock units that vest gradually through 2030.

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Roth Yiftach

(Last) (First) (Middle)

16 HARTUM STREET, RAD TOWER, 14TH FLOOR

HAR HAHOTZVIM

(Street)

JERUSALEM 9777516

(City) (State) (Zip)

ISRAEL

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
03/18/2026

3. Issuer Name and Ticker or Trading Symbol
Brainsway Ltd. [ BWAY ]

3a. Foreign Trading Symbol
[BWAY]

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Scientist

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Ordinary Shares(1)(2)	1,079,305	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

2. This figure includes: (i) 1,059,305 ordinary shares held jointly by Dr. Roth and his spouse, (ii) 14,062 ordinary shares and (iii) unvested restricted stock units ("RSUs"), with each RSU representing a contingent right to receive one ordinary share, as follows: (a) RSUs to receive 938 ordinary shares vesting in equal quarterly installments until May 11, 2026 and (b) RSUs to receive 5,000 ordinary shares with 1,250 vesting on March 10, 2027 and the remainder vesting in equal quarterly installments until March 10, 2030.

	/s/ Yiftach Roth	03/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)

FAQ

What does Brainsway (BWAY) insider Yiftach Roth report on this Form 3?

Dr. Yiftach Roth reports his initial beneficial ownership of Brainsway. He discloses 1,079,305 Ordinary Shares, including jointly held shares, individually held shares, and unvested RSUs that may convert into shares over time, establishing his baseline equity stake as Chief Scientist.

How many Brainsway (BWAY) shares does Yiftach Roth beneficially own?

He reports beneficial ownership of 1,079,305 Ordinary Shares. This total combines 1,059,305 shares held jointly with his spouse, 14,062 additional shares, and unvested RSUs, each representing a contingent right to receive one Ordinary Share as they vest over several years.

What RSU awards are included in Yiftach Roth’s Brainsway (BWAY) holdings?

His holdings include RSUs to receive 938 Ordinary Shares vesting in equal quarterly installments until May 11, 2026, and RSUs to receive 5,000 Ordinary Shares, with 1,250 vesting on March 10, 2027 and the remainder vesting quarterly until March 10, 2030.

Does this Brainsway (BWAY) Form 3 show any recent insider buying or selling?

The Form 3 does not report new purchases or sales. It serves as an initial statement of beneficial ownership, listing Dr. Roth’s existing Ordinary Shares and unvested RSUs rather than documenting a new transaction in the company’s stock.

Can Brainsway (BWAY) Ordinary Shares be held as American Depositary Shares (ADS)?

Yes. The disclosure notes that Brainsway’s Ordinary Shares may be represented by American Depositary Shares. Each ADS currently represents one Ordinary Share, providing an alternative way for investors to hold an equivalent economic interest in the company.

What role does Yiftach Roth hold at Brainsway (BWAY) in this filing?

He is identified as an officer of Brainsway, serving as Chief Scientist. The Form 3 links his reported equity stake to this executive role, giving transparency into the ownership position of a key member of the company’s leadership team.